Paritosh Garg/LinkedIn
Apr 12, 2026, 14:15
Paritosh Garg: A fibrotic marrow is not always PMF
Paritosh Garg, Associate Consultant at Fortis Memorial Research Institute, India, shared a post on LinkedIn:
“A fibrotic marrow is not always PMF.
One recent case reminded me of this very clearly.
A young woman presented with severe cytopenias, a leucoerythroblastic smear, and grade 2 marrow fibrosis.
The initial marrow appearance was concerning — but the rest of the story mattered.
There was:
- no splenomegaly
- no atypical megakaryocytes
- no significant dysplasia
- no convincing clonal marker
- autoimmune features supporting an immune-mediated process
Her treatment journey was equally telling:
- relapsed on steroids
- did not respond to MMF / cyclosporine / danazol
- finally responded to rituximab
For me, the takeaway was powerful:
- when fibrosis is seen in the marrow, especially in a young patient with autoimmune clues, autoimmune myelofibrosis must remain on the radar.
In hematology, morphology opens the door.
But diagnosis still belongs to the whole clinical picture.”
Stay updated with Hemostasis Today.
-
May 13, 2026, 17:38Rohit Sankar J. Snscphysio: Recognizing the Clot Before It Becomes Life-Threatening
-
May 13, 2026, 16:41Seema Dawood: When Elevated Platelets Signal a Myeloproliferative Neoplasm
-
May 13, 2026, 16:38Kari Tikkinen: Defining Thromboprophylaxis in MIBC Neoadjuvant Care
-
May 13, 2026, 16:28Nadia Tarhini: Evaluating the Risk of Recurrent Thrombosis in Children with ALL
-
May 13, 2026, 16:01Sifat Jubaira: When Low MCV Meets High Platelets
-
May 13, 2026, 15:58Aktham El-rekaby: Immunothrombosis in Acute Ischaemic Stroke
-
May 13, 2026, 15:49Alison Dougall: Oral Health and Cardiovascular Risk in Bleeding Disorders
-
May 13, 2026, 15:38International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk
-
May 13, 2026, 15:19Papa Heme։ Causes of Isolated Prolonged aPTT Without Bleeding